FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories Carvedilol Tablets Recall

Carvedilol Tablets USP, 12

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories · La Vergne, TN

Risk level
Class II
Reported by FDA
Aug 27, 2025
Recall ID
D-0594-2025
Check your lot numberHow we source this data

Summary

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalled Carvedilol Tablets starting Aug 20, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0594-2025 on Aug 27, 2025. Reason: CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm. Status: Ongoing.

Why it was recalled

CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm

Product description

Carvedilol Tablets USP, 12.5 mg, 100- Tablets, (10x10) cartons, Rx Only, Packaged and distributed by Major Pharmaceuticals, Indianapolis, IN, 46268, USA, NDC 0904-7307-61

Lot numbers, UPCs & expiration codes

Lot #: T05693, Exp. Date 03/2026

Where it was sold

Product was distributed nationwide within the United States.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0594-2025
Classification
Class II
Status
Ongoing
Recall initiated
Aug 20, 2025
FDA report date
Aug 27, 2025
Quantity
26,628 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Original FDA data

Every field from FDA enforcement report D-0594-2025, exactly as published.

Show all FDA fields
City
La Vergne
State
TN
Status
Ongoing
Country
United States
Event ID
97449
Address
341 Mason Rd
Code information
Lot #: T05693, Exp. Date 03/2026
Postal code
37086-3606
Report date
Aug 27, 2025
Product type
Drugs
Recall number
D-0594-2025
Classification
Class II
Recalling firm
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Product quantity
26,628 cartons
Reason for recall
CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm
Voluntary / mandated
Voluntary: Firm initiated
Product description
Carvedilol Tablets USP, 12.5 mg, 100- Tablets, (10x10) cartons, Rx Only, Packaged and distributed by Major Pharmaceuticals, Indianapolis, IN, 46268, USA, NDC 0904-7307-61
Distribution pattern
Product was distributed nationwide within the United States.
Recall initiation date
Aug 20, 2025
Initial firm notification
Letter
Center classification date
Aug 21, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0594-2025, published Aug 27, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls